NCT03098160 2017-10-30Immunotherapy Study of Evofosfamide in Combination With IpilimumabThreshold PharmaceuticalsPhase 1 Unknown69 enrolled
NCT01522872 2016-06-02Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple MyelomaThreshold PharmaceuticalsPhase 1/2 Unknown98 enrolled
NCT02020226 2016-06-02A Cardiac Safety Study of TH-302 in Patients With Advanced Solid TumorsThreshold PharmaceuticalsPhase 1 Unknown40 enrolled